Cathryn Brock

Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer

David J. Pinato, Sarah Howlett, Diego Ottaviani et al. · JAMA Oncology · 2019 · 593 citations · Full text

Medicine, Oncology, Pharmacology +15

Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral Mammalian Target of Rapamycin Inhibitor Everolimus in Patients With Advanced Solid Tumors

Anne O’Donnell, Sandrine Faivre, Howard A. Burris et al. · Journal of Clinical Oncology · 2008 · 479 citations

Pharmacy, Oncology, Pharmacology +17

A New Model for Prediction of Drug Distribution in Tumor and Normal Tissues: Pharmacokinetics of Temozolomide in Glioma Patients

Lula Rosso, Cathryn Brock, James M. Gallo et al. · Cancer Research · 2008 · 161 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Metabolic activation of temozolomide measured in vivo using positron emission tomography.

Azeem Saleem, Gavin Brown, Frank Brady et al. · PubMed · 2003 · 91 citations

Medicine, Pharmacokinetics, Pharmacology +17

Pharmacokinetic assessment of novel anti-cancer drugs using spectral analysis and positron emission tomography: A feasibility study

Steven R. Meikle, Julian C. Matthews, Cathryn Brock et al. · Cancer Chemotherapy and Pharmacology · 1998 · 57 citations

Medicine, Pharmacokinetics, Pharmacology +17